The global HPV therapeutic vaccines market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The major factors that are fuelling the growth of the market include a growing number of cervical cancer patients globally, due to HPV infection, along with growing awareness about health among the people. Moreover, the increasing incidence of HPV is a major driving factor for the market. However, low adoption rates and stringent regulatory policies requiring long-term studies of vaccines and their efficacies are the hindrance factors for the market growth.
To Request a Sample of our Report on Global HPV Therapeutic Vaccines Market: https://www.omrglobal.com/request-sample/hpv-therapeutic-vaccines-market
Human papillomavirus (HPV) therapeutic vaccines are used to protect against HPV infections. They are sexually transmitted through the skin and mucous of the infected person. Sexually transmitted HPV infection can be categorized as low-risk HPVs and high-risk HPVs. Low-risk HPV causes skin warts around genitals, anus, mouth, or throat, and could lead to respiratory papillomatosis; whereas, high-risk HPV causes cancer such as cervical, anal, oropharyngeal cancers, and other rare cancers. The incidence of genital HPV infections in the US is approximately 14 million per year. Currently, there are three FDA-approved HPV therapeutic vaccines available in the market, namely, Gardasil, Gardasil 9, and Cervarix. These vaccines are effective in preventing infections caused by two high-risk HPVs (HPV types 16 and 18), which are responsible for causing about 70% of cervical cancers. Thus, the rise in the cases of HPV is driving the growth of the market. The key players in the market are adopting several strategies such as product launches, and mergers and acquisitions, among others to remain competitive in the market. For instance, In September 2019, GlaxoSmithKline teamed up with China-based company Xiamen Innovax Biotech for the development and commercialization of HPV vaccines.
Market Coverage
· The market number available for – 2020-2027
· Base year- 2020
· Forecast period- 2021-2027
· Segment Covered
· Regions Covered- Globally
· Competitive Landscape: Pfizer Inc., GlaxoSmithKline plc, and Merck & Co., Inc., among others.
(Get 15% Discount on Buying this Report)
A full Report of Global HPV Therapeutic Vaccines Market is Available at: https://www.omrglobal.com/industry-reports/hpv-therapeutic-vaccines-market
Global HPV Therapeutic Vaccines Market Report by Segment
By Adjuvants
• Bivalent HPV Vaccine
• Quadrivalent HPV Vaccine
Global HPV Therapeutic Vaccines Market by Region
North America
· United States
· Canada
Europe
· UK
· Germany
· Spain
· France
· Italy
· Rest of Europe
Asia-Pacific
· India
· China
· Japan
· South Korea
· Rest of APAC
Rest of the World
Reasons to buy from us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
(This release has been published on Global Market Post. Global Market Post is not responsible for any content included in this release.)
